时间 | 题目 | 讲者 |
---|---|---|
13:30-13:45 |
Innate immune effector ISG12a promotes anticancer immunity of NK cells through suppressing canonical Wnt/β-catenin signaling pathway |
朱海珍 |
Haizhen Zhu | ||
13:45-14:00 |
NK细胞与肿瘤免疫微环境 |
郑小虎 |
Xiaohu Zheng | ||
14:00-14:10 |
METTL3介导的m6A甲基修饰促进NK细胞抗肿瘤免疫 |
宋浩 |
Hao Song | ||
14:10-14:20 |
Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors |
李洋洋 |
Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors |
Yangyang Li | |
14:20-14:30 |
NAD+ salvage governs the mitochondrial homeostasis and functional response of NK cells |
郭小维 |
NAD+ salvage governs the mitochondrial homeostasis and functional response of NK cells |
Xiaowei Guo | |
14:30-14:40 |
STING signaling is critical for γδ T cell-mediated tumor immunity |
骆静 |
STING signaling is critical for γδ T cell-mediated tumor immunity |
Jing Luo | |
14:40-14:50 |
Cystathionine β-synthase-mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis |
周玉付 |
Cystathionine β-synthase-mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis |
yufu zhou |
时间 | 题目 | 讲者 |
---|---|---|
15:10-15:25 |
NKG7 mRNA therapy increases the anti-tumor cytotoxicity of CD8+ T cells and improves response to immune checkpoint inhibitors |
温倜 |
NKG7 mRNA therapy increases the anti-tumor cytotoxicity of CD8+ T cells and improves response to immune checkpoint inhibitors |
Ti Wen | |
15:25-15:40 |
JAK1 plays as a key target for T-cell resistance |
韩萍 |
JAK1 plays as a key target for T-cell resistance |
Ping Han | |
15:40-15:50 |
Tumor metabolite lactate promotes tumorigenesis through regulating regulatory T cells by modulating Moesin lactylation and enhancing TGF-beta signaling |
古鉴 |
Tumor metabolite lactate promotes tumorigenesis through regulating regulatory T cells by modulating Moesin lactylation and enhancing TGF-beta signaling |
鉴 古 | |
15:50-16:00 |
CCDC134在CD8+T细胞稳态及活化调节中的作用及其机制研究 |
史倩文 |
Qianwen Shi | ||
16:00-16:10 |
CMC1作为免疫代谢检查点在T细胞早期激活中的作用 |
高洁 |
Jie Gao | ||
16:10-16:20 |
组蛋白去甲基化酶LSD1促进肿瘤CD8 T细胞耗竭 |
生万强 |
Wanqiang Sheng |